Entong Wang1, Min Zhao, John V Forrester, Colin D McCaig. 1. Department of Biomedical Sciences, Institute of Medical Sciences, Medical School, University of Aberdeen, Aberdeen AB25 2ZD, Scotland, United Kingdom.
Abstract
PURPOSE: To use lens epithelial cell monolayer wounds as a model system for the aberrant cell migration underlying posterior capsule opacification (PCO) and to investigate the effects of an applied physiological electric field (EF) on monolayer wound healing. METHODS: Scratch wounds were made in cultured bovine lens epithelial monolayers, and the wounds were exposed to an EF, with or without U0126 treatment (an inhibitor of active extracellular signal-regulated kinase [ERK 1/2]). Serial wound images were taken and wound areas were measured. Western blot analysis and immunocytochemical staining for ERK 1/2 in the wounded monolayers were performed. RESULTS: An applied EF of a given polarity influenced the healing of lens epithelial monolayer wounds. Wounds facing the anode healed at normal rates, those facing the cathode closed much more slowly. U0126, an inhibitor of mitogen-activated protein kinase (MAPK) signaling, inhibited wound healing, with or without exposure to an EF. Western blot analysis showed that both wounding and application of an EF enhanced the activation of ERK 1/2 independently and that U0126 completely inhibited these activations of ERK 1/2 in monolayers. Immunocytochemical staining showed an asymmetric activation of ERK 1/2 in EF-exposed wounds, with much weaker fluorescence in cathode-facing wounds, which could contribute to differentially directed wound-healing rates in an EF. CONCLUSIONS: Exposure to an EF inhibited the healing of lens epithelial monolayer wounds facing the cathode. ERK signaling pathways were involved in healing of lens epithelial monolayer wounds and in the EF-directed migration of the wound edge. It may be possible to use an applied EF to regulate the aberrant migration of lens epithelial cells that results in PCO after cataract surgery.
PURPOSE: To use lens epithelial cell monolayer wounds as a model system for the aberrant cell migration underlying posterior capsule opacification (PCO) and to investigate the effects of an applied physiological electric field (EF) on monolayer wound healing. METHODS: Scratch wounds were made in cultured bovine lens epithelial monolayers, and the wounds were exposed to an EF, with or without U0126 treatment (an inhibitor of active extracellular signal-regulated kinase [ERK 1/2]). Serial wound images were taken and wound areas were measured. Western blot analysis and immunocytochemical staining for ERK 1/2 in the wounded monolayers were performed. RESULTS: An applied EF of a given polarity influenced the healing of lens epithelial monolayer wounds. Wounds facing the anode healed at normal rates, those facing the cathode closed much more slowly. U0126, an inhibitor of mitogen-activated protein kinase (MAPK) signaling, inhibited wound healing, with or without exposure to an EF. Western blot analysis showed that both wounding and application of an EF enhanced the activation of ERK 1/2 independently and that U0126 completely inhibited these activations of ERK 1/2 in monolayers. Immunocytochemical staining showed an asymmetric activation of ERK 1/2 in EF-exposed wounds, with much weaker fluorescence in cathode-facing wounds, which could contribute to differentially directed wound-healing rates in an EF. CONCLUSIONS: Exposure to an EF inhibited the healing of lens epithelial monolayer wounds facing the cathode. ERK signaling pathways were involved in healing of lens epithelial monolayer wounds and in the EF-directed migration of the wound edge. It may be possible to use an applied EF to regulate the aberrant migration of lens epithelial cells that results in PCO after cataract surgery.
Authors: Kujaany Kana; Hannah Song; Carol Laschinger; Peter W Zandstra; Milica Radisic Journal: Tissue Eng Part A Date: 2015-08-07 Impact factor: 3.845
Authors: Shahed Y Ghoghawala; Mark J Mannis; Christine E Pullar; Mark I Rosenblatt; R Rivkah Isseroff Journal: Invest Ophthalmol Vis Sci Date: 2008-05 Impact factor: 4.799
Authors: Dalia H Abdelkader; Murtaza M Tambuwala; Christopher A Mitchell; Mohamed A Osman; Sanaa A El-Gizawy; Ahmed M Faheem; Mohamed El-Tanani; Paul A McCarron Journal: Drug Deliv Transl Res Date: 2018-10 Impact factor: 4.617
Authors: Ting-Xin Jiang; Ang Li; Chih-Min Lin; Cathleen Chiu; Jung-Hwa Cho; Brian Reid; Min Zhao; Robert H Chow; Randall Bruce Widelitz; Cheng-Ming Chuong Journal: iScience Date: 2021-05-31